← Back to Vaccine Database

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)

Protein based vaccine · VDDBV0642

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials5

NCT IDPhaseDisease / Condition
NCT05050474 Phase 1COVID-19
NCT05238649 Phase 2COVID-19
NCT05239832 Phase 2COVID-19
NCT05096845 Phase 3COVID-19
NCT05096832 Phase 3COVID-19